PS
Pavneet Singh Kalra
About Pavneet Singh Kalra
Data last updated:
Pavneet Singh Kalra is an Additional Director at Systole Remedies Private Limited (since 2021) and Director at Flanca Life Sciences Private Limited (since 2022). The companies operate in Pharma. The largest current company by reported revenue is Systole Remedies Private Limited at ₹59.68 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Systole Remedies Private Limited U24230DL2005PTC191854 | Additional Director | 13 Jul 2021 | 2005 | ₹59.68 Cr (FY 2025) | Active |
 Flanca Life Sciences Private Limited U51909CH2022PTC044768 | Director | 30 Dec 2022 | 2022 | Active |
Board colleagues of Pavneet Singh Kalra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Thakur | 11324034 | Systole Remedies Private Limited | Director |
| Harsimran Singh Kalra | 08445853 | Systole Remedies Private Limited , Flanca Life Sciences Private Limited | Additional Director |
| Jitender Mohan Kalra | 08544394 | Systole Remedies Private Limited , Flanca Life Sciences Private Limited | Additional Director |
| Mandeep Singh Kalra | 09240146 | Systole Remedies Private Limited , Flanca Life Sciences Private Limited | Additional Director |
| Pawan Kumar | 03336280 | Systole Remedies Private Limited | Person Incharge |
| Ravneet Singh | 08445822 | Systole Remedies Private Limited , Flanca Life Sciences Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pavneet Singh Kalra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pavneet Singh Kalra
Pavneet Singh Kalra currently holds 2 directorships: Systole Remedies Private Limited (Additional Director, since 13 Jul 2021, revenue ₹59.68 Cr (FY 2025)); Flanca Life Sciences Private Limited (Director, since 30 Dec 2022).
Pavneet Singh Kalra was first appointed on 13 Jul 2021 as Additional Director at Systole Remedies Private Limited. The most recent appointment on record is 30 Dec 2022 at Flanca Life Sciences Private Limited.
The current boards of Pavneet Singh Kalra's companies include Ashok Thakur (Systole Remedies Private Limited), Harsimran Singh Kalra (Systole Remedies Private Limited), Jitender Mohan Kalra (Systole Remedies Private Limited), Mandeep Singh Kalra (Systole Remedies Private Limited), Pawan Kumar (Systole Remedies Private Limited), Ravneet Singh (Systole Remedies Private Limited).